Distribution and developmental changes in vasopressin V2 receptor mRNA in rat brain. 1995

Y Kato, and N Igarashi, and A Hirasawa, and G Tsujimoto, and M Kobayashi
Department of Pathology, Tokyo Women's Medical College, Japan.

The extrarenal presence of vasopressin V2 receptors (V2Rs) has been suggested but never been demonstrated. We investigated the distribution of V2R mRNA expression in the brain of newborn and adult rats using the reverse transcription-polymerase chain reaction (RT-PCR) and in situ hybridization (ISH). RT-PCR assay revealed V2R mRNA in the cerebellum of both newborn and adult rats, and in the cerebrum of newborn but not adult rats. Further examination of the newborn rat brain by ISH showed dense localization of that V2R mRNA in the choroid plexus, and the neurons of the hippocampus and granular layer of the cerebellum. Epithelial cells and vascular endothelial cells were strongly stained in the choroid plexus. Moreover, expression of V2R mRNA in the hippocampus of the newborn rat decreased with age and could not be detected in rats more than 2 weeks old, while in the cerebellum V2R mRNA expression was stable and did not change with development. The results of our study have demonstrated the presence and distribution of V2R in the brain for the first time, and also show that expression of V2R mRNA in the hippocampus changes dynamically during the process of development. V2R may play an important role in the development of the central nervous system.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D017403 In Situ Hybridization A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes. Hybridization in Situ,Hybridization, In Situ,Hybridizations, In Situ,In Situ Hybridizations

Related Publications

Y Kato, and N Igarashi, and A Hirasawa, and G Tsujimoto, and M Kobayashi
March 1994, European journal of pharmacology,
Y Kato, and N Igarashi, and A Hirasawa, and G Tsujimoto, and M Kobayashi
June 1997, The American journal of physiology,
Y Kato, and N Igarashi, and A Hirasawa, and G Tsujimoto, and M Kobayashi
December 1994, Biochemical and biophysical research communications,
Y Kato, and N Igarashi, and A Hirasawa, and G Tsujimoto, and M Kobayashi
July 1992, Endocrinology,
Y Kato, and N Igarashi, and A Hirasawa, and G Tsujimoto, and M Kobayashi
May 1998, Clinical science (London, England : 1979),
Y Kato, and N Igarashi, and A Hirasawa, and G Tsujimoto, and M Kobayashi
January 1996, Peptides,
Y Kato, and N Igarashi, and A Hirasawa, and G Tsujimoto, and M Kobayashi
August 2001, Cardiovascular research,
Y Kato, and N Igarashi, and A Hirasawa, and G Tsujimoto, and M Kobayashi
January 2020, Vitamins and hormones,
Y Kato, and N Igarashi, and A Hirasawa, and G Tsujimoto, and M Kobayashi
August 2002, Journal of molecular endocrinology,
Y Kato, and N Igarashi, and A Hirasawa, and G Tsujimoto, and M Kobayashi
March 1992, Neurochemistry international,
Copied contents to your clipboard!